THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Their prescri...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-12-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/585 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227870748016640 |
|---|---|
| author | R. I. Striuk Ya. V. Brytkova |
| author_facet | R. I. Striuk Ya. V. Brytkova |
| author_sort | R. I. Striuk |
| collection | DOAJ |
| description | Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Their prescription in different clinical situations meets the principle of "risk–benefit". Fetus and newborn status should be monitored because β-AB can cause bradycardia, hypoglycemia, apnea and metabolic disorders. The risk of these side effects is extremely low, while β-AB clinical efficacy is high. |
| format | Article |
| id | doaj-art-6e1871fa2f6e4b2eb10f2f701bd41da4 |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2015-12-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-6e1871fa2f6e4b2eb10f2f701bd41da42025-08-23T10:00:20ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-12-018569970210.20996/1819-6446-2012-8-5-699-702584THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMENR. I. Striuk0Ya. V. Brytkova1Moscow State University of Medicine and Dentistry named after A.I. EvdokimovMoscow State University of Medicine and Dentistry named after A.I. EvdokimovHighly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Their prescription in different clinical situations meets the principle of "risk–benefit". Fetus and newborn status should be monitored because β-AB can cause bradycardia, hypoglycemia, apnea and metabolic disorders. The risk of these side effects is extremely low, while β-AB clinical efficacy is high.https://www.rpcardio.online/jour/article/view/585β-adrenoblockerspregnancysafety for the fetusarterial hypertensionarrhythmiamarfan syndromehypertrophic cardiomyopathy |
| spellingShingle | R. I. Striuk Ya. V. Brytkova THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN Рациональная фармакотерапия в кардиологии β-adrenoblockers pregnancy safety for the fetus arterial hypertension arrhythmia marfan syndrome hypertrophic cardiomyopathy |
| title | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN |
| title_full | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN |
| title_fullStr | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN |
| title_full_unstemmed | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN |
| title_short | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN |
| title_sort | role of beta blockers in the treatment of cardiovascular diseases in pregnant women |
| topic | β-adrenoblockers pregnancy safety for the fetus arterial hypertension arrhythmia marfan syndrome hypertrophic cardiomyopathy |
| url | https://www.rpcardio.online/jour/article/view/585 |
| work_keys_str_mv | AT ristriuk theroleofbetablockersinthetreatmentofcardiovasculardiseasesinpregnantwomen AT yavbrytkova theroleofbetablockersinthetreatmentofcardiovasculardiseasesinpregnantwomen AT ristriuk roleofbetablockersinthetreatmentofcardiovasculardiseasesinpregnantwomen AT yavbrytkova roleofbetablockersinthetreatmentofcardiovasculardiseasesinpregnantwomen |